Maria Eva M. C.
- Country
- Spain
- Department
- Hematology
Research Overview
- Safety and Preliminary Efficacy of CTX112 in Adults with Relapsed or Refractory Hematologic Autoimmune Disease
- Evaluation of Nipocalimab for Reducing Severe Fetal and Neonatal Alloimmune Thrombocytopenia Risk in At-risk Pregnancies: A Double-blind, Randomized, Placebo-controlled Trial
- A Multicenter, Randomized, Open-Label Study Comparing Romiplostim Plus Dexamethasone Versus Dexamethasone in Newly Diagnosed Primary Immune Thrombocytopenia
Data & Insights
Has run more than one trial at 104 of 159 partner sites.
Specializations
Thrombocytopenic Conditions
The investigator specializes in treating various forms of immune thrombocytopenia, including primary immune thrombocytopenia (ITP) and thrombotic thrombocytopenic purpura (TTP). Their work extends to both newly diagnosed cases and refractory/relapsed conditions.
- Primary ITP Management
- Immune-mediated TTP Treatment
- Refractory Thrombocytopenia
Autoimmune Hematologic Disorders
Focuses on treating complex autoimmune blood disorders, particularly warm autoimmune hemolytic anemia (wAIHA) and cold agglutinin disease (CAD). The investigator works with novel therapeutic approaches for these challenging conditions.
- Hemolytic Anemia Treatment
- Autoimmune Cytopenia Management
- Complement Pathway Disorders
Specialized Immunological Conditions
Has expertise in treating various immunological disorders including antiphospholipid syndrome, Behçet's Syndrome, and immune-mediated necrotizing myopathy. Their work also encompasses bullous pemphigoid and dermatomyositis.
- Autoimmune Disease Management
- Immunosuppressive Therapy
- Maternal-Fetal Medicine
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.